Phibro Animal Health (PAHC) Gross Profit Growth (3y) (2015 - 2026)

Phibro Animal Health (PAHC) Gross Profit Growth (3y) (2015 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Profit Growth (3y) (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn 7.62%
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn 4.71%
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn -7.64%
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn 12.55%
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn -9.13%
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 24.80%
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn 0.95%
10 Phibro Animal Health 1.43 Bn 1.35 Bn 125.68 Mn 18.49%

Historic Data

Download Data
DateValue
Mar 31, 2026 18.49%
Dec 31, 2025 19.68%
Sep 30, 2025 20.39%
Jun 30, 2025 11.94%
Mar 31, 2025 13.44%
Dec 31, 2024 12.96%
Sep 30, 2024 8.88%
Jun 30, 2024 7.67%
Mar 31, 2024 4.80%
Dec 31, 2023 4.82%
Sep 30, 2023 1.84%
Jun 30, 2023 8.18%
Mar 31, 2023 2.79%
Dec 31, 2022 3.84%
Sep 30, 2022 5.98%
Jun 30, 2022 6.29%
Mar 31, 2022 3.36%
Dec 31, 2021 0.98%
Sep 30, 2021 -0.57%
Jun 30, 2021 1.13%